United Therapeutics Corporation (UTHR) — Capital Reinvestment Ratio
United Therapeutics Corporation (UTHR) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow ($562.10 Million) in capital expenditures ($210.50 Million). See how leveraged is United Therapeutics Corporation's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
United Therapeutics Corporation Capital Reinvestment Ratio (2004–2024)
This chart tracks United Therapeutics Corporation's Capital Reinvestment Ratio across 19 annual periods. Check total reinvestment intensity of United Therapeutics Corporation to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for United Therapeutics Corporation (2004–2024)
Year-by-year Capital Reinvestment Ratio for United Therapeutics Corporation from 2004 to 2024. For live market cap and broader valuation context, see United Therapeutics Corporation (UTHR) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | $1.33 Billion | $246.50 Million | ▼ -21.2% |
| 2023 | 0.24x | $978.00 Million | $230.40 Million | ▲ +36.2% |
| 2022 | 0.17x | $802.50 Million | $138.80 Million | ▼ -14.4% |
| 2021 | 0.20x | $598.20 Million | $120.80 Million | ▲ +157.3% |
| 2020 | 0.08x | $755.70 Million | $59.30 Million | ▼ -66.9% |
| 2018 | 0.24x | $778.40 Million | $184.40 Million | ▲ +30.2% |
| 2017 | 0.18x | $474.20 Million | $86.30 Million | ▲ +171.1% |
| 2016 | 0.07x | $643.60 Million | $43.20 Million | ▼ -48.4% |
| 2015 | 0.13x | $382.80 Million | $49.79 Million | ▼ -2.6% |
| 2014 | 0.13x | $355.30 Million | $47.44 Million | ▲ +77.9% |
| 2013 | 0.08x | $425.27 Million | $31.91 Million | ▼ -78.3% |
| 2012 | 0.35x | $323.63 Million | $111.91 Million | ▲ +140.5% |
| 2011 | 0.14x | $250.19 Million | $35.98 Million | ▲ +63.2% |
| 2010 | 0.09x | $211.53 Million | $18.64 Million | ▼ -90.8% |
| 2009 | 0.96x | $99.72 Million | $95.40 Million | ▲ +21.1% |
| 2007 | 0.79x | $48.95 Million | $38.66 Million | ▲ +149.5% |
| 2006 | 0.32x | $49.39 Million | $15.63 Million | ▲ +123.4% |
| 2005 | 0.14x | $43.17 Million | $6.12 Million | ▼ -43.6% |
| 2004 | 0.25x | $20.78 Million | $5.22 Million | — |